HTLDACOBLMATOH-UHFFFAOYSA-N
C28H27F3N10O3 — CID 118621000
Data last refreshed: (MolForge compound catalog, from PubChem)
About HTLDACOBLMATOH-UHFFFAOYSA-N
HTLDACOBLMATOH-UHFFFAOYSA-N (PubChem CID 118621000) has the molecular formula C28H27F3N10O3 and a molecular weight of 608.59 g/mol. Its IUPAC name is 1-[4-(6-cyclopropyl-5-pyrimidin-5-yl-7H-pyrrolo[2,3-c]pyridazin-3-yl)butyl]-N-(pyridin-2-ylmethyl)triazole-4-carboxamide;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | HTLDACOBLMATOH-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 118621000 |
| Molecular Formula | C28H27F3N10O3 |
| Molecular Weight | 608.59 g/mol |
| Exact Mass | 608.22 |
| IUPAC Name | 1-[4-(6-cyclopropyl-5-pyrimidin-5-yl-7H-pyrrolo[2,3-c]pyridazin-3-yl)butyl]-N-(pyridin-2-ylmethyl)triazole-4-carboxamide;2,2,2-trifluoroacetic acid |
| SMILES | O=C(NCc1ccccn1)c1cn(CCCCc2cc3c(-c4cncnc4)c(C4CC4)[nH]c3nn2)nn1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C26H26N10O.C2HF3O2/c37-26(30-14-20-6-1-3-9-29-20)22-15-36(35-33-22)10-4-2-5-19-11-21-23(18-12-27-16-28-13-18)24(17-7-8-17)31-25(21)34-32-19;3-2(4,5)1(6)7/h1,3,6,9,11-13,15-17H,2,4-5,7-8,10,14H2,(H,30,37)(H,31,34);(H,6,7) |
| InChIKey | HTLDACOBLMATOH-UHFFFAOYSA-N |
| XLogP | 3.87 |
| TPSA | 177.35 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 608.59 |
| LogP ≤ 5 | 3.87 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118621000 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.